Wedbush's Ives blasts Elon Musk, removes Tesla (TSLA) stock from Best Idea List
Get Alerts TSLA Hot Sheet
Rating Summary:
29 Buy, 26 Hold, 16 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Join SI Premium – FREE
Wedbush analyst Daniel Ives removed Tesla (NASDAQ: TSLA) from the firm’s Best Idea List and cut the price target to $250 per share from $300. The analyst’s near-term view of Tesla stock is “increasingly becoming more challenged” after CEO Elon Musk completed the Twitter takeover.
Ives said that Tesla investors “have been punched again and again by the Musk Twitter antics,” placing shares in the “deep” penalty box in the next couple of months. The first catalyst that could help Tesla shares to re-rate is Q4 deliveries, which should be presented at the beginning of January.
“Musk has essentially tarnished the Tesla story/stock and is starting to potentially impact the Tesla brand with this ongoing Twitter train wreck disaster,” Ives said in a client note.
“Tesla is Musk,” added Ives and reminded the CEO of SpaceX that it was the electric vehicle (EV) maker that made him a billionaire in the first place.
“And now sitting on top of the peak of the mountain with Tesla in a massive position of strength Musk has managed to do what the bears have unsuccessfully tried for years...crush Tesla's stock by his own doing in what we view as a purely painful dark situation,” added Ives.
Tesla shares are down about 25% since the Twitter deal was closed and nearly double that since Musk first made a bid to take the social media company private.
The lower price target reflects a lower multiple due to the “Musk overhang that gets worse by the day,” Ives concluded.
Tesla's stock price closed 7.17% lower yesterday, hitting fresh 2-year lows.
By Senad Karaahmetovic
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
- Eledon Pharamceuticals (ELDN) PT Raised to $7 at Leerink
- Taysha Gene Therapies (TSHA) PT Raised to $10 at BofA Securities
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT Change, Hot Comments, Hot ListRelated Entities
Twitter, Tesla, Senad KaraahmetovicSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share